Caprock Group, Inc. Emergent Bio Solutions Inc. Transaction History

Caprock Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$81.91 - $134.94 $221,157 - $364,338	-2,700 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $146,691 - $241,704	2,700 New	2,700 $214,000
Q2 2019 Jul 23, 2019	SELL	$39.92 - $53.86 $180,478 - $243,501	-4,521 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$48.23 - $66.16 $10,996 - $15,084	-228 Reduced 4.8%	4,521 $228,000
Q4 2018 Jan 29, 2019	SELL	$55.63 - $73.24 $15,576 - $20,507	-280 Reduced 5.57%	4,749 $282,000
Q3 2018 Oct 17, 2018	SELL	$52.05 - $66.51 $8,015 - $10,242	-154 Reduced 2.97%	5,029 $331,000
Q2 2018 Jul 23, 2018	SELL	$48.33 - $55.64 $18,123 - $20,865	-375 Reduced 6.75%	5,183 $262,000
Q1 2018 Apr 23, 2018	BUY	$44.44 - $54.39 $246,997 - $302,299	5,558 New	5,558 $293,000

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $416M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.